Chemoinformaics analysis of (Z)-3-Hexenyl hexadecanoate
| Molecular Weight | 338.576 | nRot | 18 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 2 |
| Exact Molecular Weight | 338.318 | nRing | 0 |
| Solubility: LogS | -5.068 | nHRing | 0 |
| Solubility: LogP | 7.878 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 66.3493 |
| nHD | 0 | BPOL | 44.7387 |
| QED | 0.148 |
| Synth | 2.204 |
| Natural Product Likeliness | 0.709 |
| NR-PPAR-gamma | 0.109 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.909 |
| MDCK | 0.0000218 |
| BBB | 0.087 |
| PPB | 0.9885 |
| VDSS | 3.003 |
| FU | 0.0109908 |
| CYP1A2-inh | 0.235 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.377 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.153 |
| CYP2c9-sub | 0.944 |
| CYP2d6-inh | 0.469 |
| CYP2d6-sub | 0.16 |
| CYP3a4-inh | 0.524 |
| CYP3a4-sub | 0.067 |
| CL | 4.745 |
| T12 | 0.521 |
| hERG | 0.497 |
| Ames | 0.023 |
| ROA | 0.05 |
| SkinSen | 0.963 |
| Carcinogencity | 0.084 |
| EI | 0.955 |
| Respiratory | 0.861 |
| NR-Aromatase | 0.212 |
| Antiviral | No |
| Prediction | 0.598949 |